Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about BIIB

Recent news which mentions BIIB

< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Cleveland Clinic, Mount Sinai and Providence won’t give Biogen’s new Alzheimer’s drug
Tickers BIIB
Tags BIIB
From MarketWatch
Cleveland Clinic, Mount Sinai and Providence won’t give Biogen’s new Alzheimer’s drug
Tickers BIIB
Tags Health/Care BIIB General
From MarketWatch
Cleveland Clinic, Mount Sinai and Providence won’t give Biogen’s new Alzheimer’s drug
Tickers BIIB
Tags Company Announcements/Warnings BIIB Biotechnology
From MarketWatch
Better Biotech Stock: Biogen vs. Annovis Bio
Tickers ANVS BIIB
Tags BIIB ANVS Market News
From Motley Fool
AMD And Biogen Lead The QQQ Lower Thursday
Tickers AMC AMD BIDU BIIB
Tags Short Ideas Small Cap BIDU
From Benzinga
BIIB Stock: The Drug Ban News That Has Biogen Stumbling Today
Tickers BIIB
Tags BIIB NASDAQ:BIIB Market News
From InvestorPlace
Biogen Shares Are Trading Lower As Cleveland Clinic, Mount Sinai Decline To Aduhelm Administration
Tickers BIIB
Tags Benzinga Short Ideas Aduhelm
From Benzinga
Biogen's Alzheimer's Drug Aduhelm Review Could Have Been Handled Differently, Says FDA Chief: STAT News
Tickers BIIB ESALF ESALY
Tags Briefs Health Care Benzinga
From Benzinga
US Medicare Starts Coverage Policy Review For Biogen's Aduhelm
Tickers BIIB
Tags Biotech BIIB FDA
From Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
Tickers ABBV AFIB ALNY ALXN
Tags PLXP ARDS ELEV
From Benzinga
Beleaguered FDA in talks for drug-company funding
Tickers BIIB
Tags BIIB
From MarketWatch
Biogen, InnoCare Collaborate On Multiple Sclerosis Candidate
Tickers BIIB
Tags Contracts News Market News
From Benzinga
Why the CDC and FDA Just Slapped Down Pfizer and Moderna
Tickers BIIB BNTX MRNA PFE
Tags Market News MRNA PFE
From Motley Fool
Tesla And Lam Research Lead The QQQ Higher Monday
Tickers BIIB COST DIA DIS
Tags After/Hours Center TSLA Short Ideas
From Benzinga
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
Tickers ALEC AMAM ANGO ATAI
Tags Small Cap Benzinga ALEC
From Benzinga
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
Tickers BIIB NVS PFE QURE
Tags QURE RHHBY Market News
From Motley Fool
FDA Requests Probe Into Staff Interactions With Biogen Ahead Of Aduhelm Approval
Tickers BIIB
Tags Benzinga General Market News
From Benzinga
FDA calls for investigation into its own approval of Biogen’s Alzheimer’s drug
Tickers BIIB SPX XBI
Tags XBI BIIB SPX
From MarketWatch
Understanding Biogen's Unusual Options Activity
Tickers BIIB
Tags BZI/UOA Market News Benzinga
From Benzinga
Cramer Shares His Thoughts On Anavex Life Sciences, Upstart And More
Tickers AVXL BIIB NIO UPST
Tags NIO mad money Lightning Round Benzinga
From Benzinga
Should Biogen Worry About a Congressional Investigation Into Its Alzheimer's Disease Drug?
Tickers BIIB
Tags BIIB Market News
From Motley Fool
What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.
Tickers BIIB CARV CNI COIN
Tags CARV KSU SHIB/USD
From InvestorPlace
Baidu And Nvidia Lead The QQQ Lower Thursday
Tickers ALGN AMZN BIDU BIIB
Tags After/Hours Center XPEV TSLA
From Benzinga
3 Blue-Chip Stocks to Trade Right Now
Tickers AMD AMZN BIIB GS
Tags INTC GS MRK
From InvestorPlace
Forget a Bear Market -- These 2 Nasdaq Stocks Are Moving Higher
Tickers BIIB GNOG LLY
Tags LLY Market News GNOG
From Motley Fool
FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients
Tickers BIIB ESALY
Tags Benzinga ESALY Health Care
From Benzinga
Oracle And CarMax Lead The SPY Higher Wednesday
Tickers AMD AMZN BIIB CCL
Tags QQQ CGC Trading Ideas
From Benzinga
< Previous 1 2
...
26 27 28 29 30 31 32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.